Law Commons^™

Can Incentives To Generic Manufacturers Save The Doha Declaration's Paragraph 6?, Stacey B. Lee

Stacey B. Lee

A primary objective of the DOHA Declaration was to create a process for member countries with insufficient manufacturing capabilities to access generic versions of patented drugs without violating TRIPS intellectual property standards. This year marks the 10^th anniversary of the process. Referred to as the “Paragraph 6 compulsory licenses provisions,” this first and only amendment to TRIPS was intended to ensure developing countries access to affordable medicines. Over the past decade, these provisions have failed to provide the gains initially anticipated. This article explores the reasons for this failure and suggests that an under-examined approach to reaching the DOHA …